GVALX
Price
$15.73
Change
-$0.03 (-0.19%)
Updated
Jul 13 closing price
Net Assets
31.98M
RMEBX
Price
$64.23
Change
-$0.20 (-0.31%)
Updated
Jul 13 closing price
Net Assets
118.05B
Interact to see
Advertisement

GVALX vs RMEBX

GVALX vs RMEBX Comparison Chart in %
View a ticker or compare two or three
VS
GVALX vs. RMEBX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GVALX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 118B vs. GVALX (32M). RMEBX pays higher dividends than GVALX: RMEBX (1.00) vs GVALX (0.80). GVALX was incepted earlier than RMEBX: GVALX (11 years) vs RMEBX (12 years). GVALX (1.19) is less costly to investors than RMEBX (1.07). GVALX is a more actively managed with annual turnover of: 200.00 vs. RMEBX (30.00). RMEBX has a lower initial minimum investment than GVALX: RMEBX (250) vs GVALX (100000). RMEBX annual gain was more profitable for investors over the last year : 8.73 vs. GVALX (7.20). RMEBX return over 5 years is better than : 36.28 vs. GVALX (-0.65).
GVALXRMEBXGVALX / RMEBX
Total Expense Ratio0.751.0770%
Annual Report Gross Expense Ratio1.191.07111%
Fund Existence11 years12 years-
Gain YTD12.0919.059133%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets32M118B0%
Annual Yield % from dividends0.801.0080%
Returns for 1 year7.208.7382%
Returns for 3 years16.8034.3049%
Returns for 5 years-0.6536.28-2%
Returns for 10 years68.3989.3677%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBTAX46.48N/A
N/A
Fidelity Advisor Biotechnology A
PURYX64.20N/A
N/A
Putnam U.S. Research Y
FCASX33.37N/A
N/A
Fidelity Advisor Asset Manager 70% C
BCAIX40.60N/A
N/A
Boston Common ESG Impact Intl
AXVNX22.07N/A
N/A
Acclivity Small Cap Value N